Persistently normal alanine aminotransferase levels in HIV/ HCV-coinfected patients: The role of steatosis

HIV Medicine

Volumn 10, Issue 7, 2009, Pages 417-421

  Bani Sadr, Firouzé ^a,i   Barange, K ^b   Daoud, F ^c   Jacomet, C ^d   Bicart See, A ^e   Rosenthal, E ^f   Cacoub, P ^g   Pol, S ^a   Perronne, C ^h   Carrat, F ^a  

^a INSERM   (France)

^b CHU PURPAN   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e Hôpital Joseph Ducuing   (France)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^g Sorbonne Université   (France)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

ⁱ HÔPITAL SAINT ANTOINE   (France)

Author keywords

HCV genotype 4; HIV HCV coinfection; Liverin flammation score; Normal alanine aminotransferase; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; FATTY LIVER; FEMALE; HEPATITIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; NORMAL VALUE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; VIRUS CELL INTERACTION; VIRUS TYPING;

EID: 67650682466     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00702.x     Document Type: Article

References (15)

1. Puoti C. HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy. J Hepatol 2003; 38: 529-532.
2. Hui CK, Belaye T, Montegrande K, Wright TL. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J Hepatol 2003; 38: 511-517.
3. Persico M, Persico E, Suozzo R et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000; 118: 760-764.
4. Carrat F, Bani-Sadr F, Pol S et al. Pegylated interferon alfa-2b vs. standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial. JAMA 2004; 292: 2839-2848.
5. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293.
6. Uberti-Foppa C, De Bona A, Galli L et al. Liver fibrosis in HIV-positive patients with hepatitis C virus: Role of persistently normal alanine aminotransferase levels. J Acquir Immune Defic Syndr 2006; 41: 63-67.
7. Maida I, Soriano V, Barreiro P, Rivas P, Labarga P, Nunez M. Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases. AIDS Res Hum Retroviruses 2007; 23: 801-804.
8. Kew MC. Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet 2000; 355: 591-592.
9. Kyrlagkitsis I, Portmann B, Smith H, O'Grady J, Cramp ME. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol 2003; 98: 1588-1593.
10. Fonquernie L, Serfaty L, Charrois A et al. Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients. HIV Med 2004; 5: 385-390.
11. Sanchez-Conde M, Berenguer J, Miralles P et al. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Clin Infect Dis 2006; 43: 640-644.
12. Fracanzani AL, Valenti L, Bugianesi E et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes. Hepatology 2008; 48: 792-798.
13. Bani-Sadr F, Carrat F, Bedossa P et al. Hepatic steatosis in HIV-HCV coinfected patients: Analysis of risk factors. AIDS 2006; 20: 525-531.
14. Fartoux L, Chazouilleres O, Wendum D, Poupon R, Serfaty L. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 2005; 41: 82-87.
15. Torti C, Lapadula G, Puoti M et al. Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: Results from the EPOKA-MASTER Cohort. J Acquir Immune Defic Syndr 2006; 41: 180-185.